Pyrazinamide resistance among drug-resistant Mycobacterium tuberculosis isolates at a referral hospital

Diagn Microbiol Infect Dis. 2013 Dec;77(4):380-1. doi: 10.1016/j.diagmicrobio.2013.08.014. Epub 2013 Sep 26.

Authors

Jyoti Arora¹, Zeeshan Sidiq, Potharaju Visalakshi, Manpreet Bhalla, Digamber Behera, Vithal Prasad Myneedu

Affiliation

¹ Department of Microbiology, Lala Ram Sarup Institute of Tuberculosis and Respiratory Diseases, Sri Aurobindo Marg, New Delhi 110030, India. Electronic address: [email protected].

PMID: 24075630
DOI: 10.1016/j.diagmicrobio.2013.08.014

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antitubercular Agents / pharmacology*
Antitubercular Agents / therapeutic use
Cross Infection*
Drug Resistance, Bacterial*
Humans
Microbial Sensitivity Tests
Mycobacterium tuberculosis / drug effects*
Mycobacterium tuberculosis / isolation & purification
Pyrazinamide / pharmacology*
Pyrazinamide / therapeutic use
Tuberculosis, Multidrug-Resistant / drug therapy
Tuberculosis, Multidrug-Resistant / microbiology*

Substances

Antitubercular Agents
Pyrazinamide